Key result
Fatty liver disease was independently associated with an increased risk of nonfatal cardiovascular events in patients undergoing maintenance hemodialysis (HR 2.84; 95% CI 1.52-5.28; p=0.001).
Why the study?
Does fatty liver disease increase the risk of nonfatal cardiovascular events in patients undergoing maintenance hemodialysis?
Cohort (n=278)
No
Does fatty liver disease increase the risk of nonfatal cardiovascular events in patients undergoing maintenance hemodialysis?
Ultrasonographically documented fatty liver disease is an independent risk factor for nonfatal cardiovascular events in patients on maintenance hemodialysis.
FLD may identify higher nonfatal CV risk in HD patients; leaves open whether screening or intervention improves outcomes.
BACKGROUND/AIMS: The prevalence of cardiovascular (CV) disease in patients undergoing maintenance hemodialysis (HD) is reportedly higher than that in healthy individuals. In the present study, we aimed to investigate whether ultrasonographically documented fatty liver disease (FLD) is an independent risk factor for nonfatal CV events in patients undergoing HD. METHODS: A retrospective cohort study was conducted in a medical center in southern Taiwan. The medical records of 490 patients undergoing HD who were enrolled between July 1998 and October 2012 were screened. Finally, 278 patients who had undergone hepatic ultrasonography and had available data were recruited in the present study. The patients included 130 men and 148 women; their mean age was 59.9 years. The primary endpoint was nonfatal CV events in the observation period. The comparable data included epidemiological, hematological, and biochemical profiles. A time-dependent statistical method was used to analyze the associated factors. RESULTS: The prevalence of nonfatal CV events was significantly increased in the patients with FLD compared with those without FLD (CV events: 32 vs. 18%, respectively; p = 0.008). After adjusting for associated risk factors (sex, age, body mass index, smoking, diabetes, hypertension, dyslipidemia, and Kt/V), multivariate analyses identified FLD (CV events: hazard ratio 2.84, 95% confidence interval 1.52-5.28, p = 0.001), advanced age, and diabetes to be independently associated with nonfatal CV events. CONCLUSION: The study suggests that FLD was an independent risk factor for nonfatal CV events in patients undergoing maintenance HD.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2014) conducted a cohort in Maintenance hemodialysis (n=278). Fatty liver disease vs. No fatty liver disease was evaluated on Nonfatal cardiovascular events (HR 2.84, 95% CI 1.52-5.28, p=0.001). Fatty liver disease was independently associated with an increased risk of nonfatal cardiovascular events in patients undergoing maintenance hemodialysis (HR 2.84; 95% CI 1.52-5.28; p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: